The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults

被引:16
作者
Asamoah-Boaheng, Michael [1 ,2 ]
Goldfarb, David M. [3 ]
Karim, Mohammad Ehsanul [4 ,5 ]
O'Brien, Sheila F. [6 ,7 ]
Wall, Nechelle [8 ]
Drews, Steven J. [6 ,9 ]
Barakauskas, Vilte [3 ]
Jassem, Agatha N. [3 ]
Grunau, Brian [1 ,4 ,8 ]
机构
[1] Univ British Columbia, Dept Emergency Med, 1190 Horby St, Vancouver, BC V6Z 2K5, Canada
[2] Mem Univ Newfoundland, Fac Med, Clin Epidemiol, St John, NL, Canada
[3] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[4] Univ British Columbia, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
[5] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[6] Canadian Blood Serv, Vancouver, BC, Canada
[7] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[8] British Columbia Emergency Hlth Serv, Vancouver, BC, Canada
[9] Univ Alberta, Div Diagnost & Appl Microbiol Lab Med & Pathol, Edmonton, AB, Canada
关键词
COVID-19; SARS-CoV-2; antibody levels; mRNA vaccine; Omicron;
D O I
10.1093/infdis/jiac403
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The relationship between antibodies to wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens and the risk of breakthrough infections is unclear, especially during circulation of the Omicron strain. We investigated the association of anti-spike and anti-receptor binding domain antibody levels and the risk of subsequent breakthrough coronavirus disease 2019 (COVID-19). We included adult paramedics from an observational cohort study who received >= 2 mRNA vaccines but did not have COVID-19 before the blood collection. Higher postvaccination antibody levels to wild-type SARS-CoV-2 antigens were associated with a reduced risk of COVID-19. Further research into clinical utility of antibody levels, to inform a threshold for protection and timing of boosters, should be prioritized.
引用
收藏
页码:339 / 343
页数:5
相关论文
共 14 条
[1]  
[Anonymous], NEW YORK TIMES
[2]   Covid-19 Breakthrough Infections in Vaccinated Health Care Workers [J].
Bergwerk, Moriah ;
Gonen, Tal ;
Lustig, Yaniv ;
Amit, Sharon ;
Lipsitch, Marc ;
Cohen, Carmit ;
Mandelboim, Michal ;
Gal Levin, Einav ;
Rubin, Carmit ;
Indenbaum, Victoria ;
Tal, Ilana ;
Zavitan, Malka ;
Zuckerman, Neta ;
Bar-Chaim, Adina ;
Kreiss, Yitshak ;
Regev-Yochay, Gili .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1474-1484
[3]  
Cavanaugh AM, 2021, MMWR-MORBID MORTAL W, V70, P1081, DOI [10.15585/mmwr.mm7032e1externalicon, 10.15585/mmwr.mm7032e1]
[4]   Evidence for antibody as a protective correlate for COVID-19 vaccines [J].
Earle, Kristen A. ;
Ambrosino, Donna M. ;
Fiore-Gartland, Andrew ;
Goldblatt, David ;
Gilbert, Peter B. ;
Siber, George R. ;
Dull, Peter ;
Plotkin, Stanley A. .
VACCINE, 2021, 39 (32) :4423-4428
[5]   Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection [J].
Feng, Shuo ;
Phillips, Daniel J. ;
White, Thomas ;
Sayal, Homesh ;
Aley, Parvinder K. ;
Bibi, Sagida ;
Dold, Christina ;
Fuskova, Michelle ;
Gilbert, Sarah C. ;
Hirsch, Ian ;
Humphries, Holly E. ;
Jepson, Brett ;
Kelly, Elizabeth J. ;
Plested, Emma ;
Shoemaker, Kathryn ;
Thomas, Kelly M. ;
Vekemans, Johan ;
Villafana, Tonya L. ;
Lambe, Teresa ;
Pollard, Andrew J. ;
Voysey, Merryn .
NATURE MEDICINE, 2021, 27 (11) :2032-+
[6]  
Gilbert Peter B, 2021, medRxiv, DOI [10.1126/science.abm3425, 10.1101/2021.08.09.21261290]
[7]  
Government of Canada, 2022, COVID 19 EP UPD
[8]   A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic [J].
Grunau, Brian ;
O'Brien, Sheila F. ;
Kirkham, Tracy L. ;
Helmer, Jennie ;
Demers, Paul A. ;
Asamoah-Boaheng, Michael ;
Drews, Steven J. ;
Karim, Mohammad Ehsanul ;
Srigley, Jocelyn A. ;
Sediqi, Sadaf ;
O'Neill, David ;
Drennan, Ian R. ;
Goldfarb, David M. .
ANNALS OF EMERGENCY MEDICINE, 2022, 80 (01) :38-45
[9]   Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection [J].
Khoury, David S. ;
Cromer, Deborah ;
Reynaldi, Arnold ;
Schlub, Timothy E. ;
Wheatley, Adam K. ;
Juno, Jennifer A. ;
Subbarao, Kanta ;
Kent, Stephen J. ;
Triccas, James A. ;
Davenport, Miles P. .
NATURE MEDICINE, 2021, 27 (07) :1205-+
[10]   COVID-19 vaccine-Long term immune decline and breakthrough infections [J].
Khoury, Johad ;
Najjar-Debbiny, Ronza ;
Hanna, Ayman ;
Jabbour, Adel ;
Abu Ahmad, Yara ;
Saffuri, Amer ;
Abu-Sinni, Majdole ;
Shkeiri, Rashed ;
Elemy, Ameer ;
Hakim, Fahed .
VACCINE, 2021, 39 (48) :6984-6989